These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16905958)

  • 41. Genetic mutation of vitamin K-dependent gamma-glutamyl carboxylase domain in patients with calcium oxalate urolithiasis.
    Qiao J; Wang T; Yang J; Liu J; Gong X; Guo X; Wang S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):604-8. PubMed ID: 19821094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. γ-Glutamyl carboxylase in osteoblasts regulates glucose metabolism in mice.
    Shiba S; Ikeda K; Azuma K; Hasegawa T; Amizuka N; Horie-Inoue K; Inoue S
    Biochem Biophys Res Commun; 2014 Oct; 453(3):350-5. PubMed ID: 25264202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in the PDS gene in German families with Pendred's syndrome: V138F is a founder mutation.
    Borck G; Roth C; Martiné U; Wildhardt G; Pohlenz J
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2916-21. PubMed ID: 12788906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.
    Bergman A; Einbeigi Z; Olofsson U; Taib Z; Wallgren A; Karlsson P; Wahlström J; Martinsson T; Nordling M
    Eur J Hum Genet; 2001 Oct; 9(10):787-93. PubMed ID: 11781691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
    Rost S; Fregin A; Ivaskevicius V; Conzelmann E; Hörtnagel K; Pelz HJ; Lappegard K; Seifried E; Scharrer I; Tuddenham EG; Müller CR; Strom TM; Oldenburg J
    Nature; 2004 Feb; 427(6974):537-41. PubMed ID: 14765194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteoblast-Specific γ-Glutamyl Carboxylase-Deficient Mice Display Enhanced Bone Formation With Aberrant Mineralization.
    Azuma K; Shiba S; Hasegawa T; Ikeda K; Urano T; Horie-Inoue K; Ouchi Y; Amizuka N; Inoue S
    J Bone Miner Res; 2015 Jul; 30(7):1245-54. PubMed ID: 25600070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haplotype analysis suggests that the two predominant mutations in Japanese patients with holocarboxylase synthetase deficiency are founder mutations.
    Yang X; Aoki Y; Li X; Sakamoto O; Hiratsuka M; Gibson KM; Kure S; Narisawa K; Matsubara Y; Suzuki Y
    J Hum Genet; 2000; 45(6):358-62. PubMed ID: 11185745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional polymorphism in gamma-glutamylcarboxylase is a risk factor for severe neonatal hemorrhage.
    Vanakker OM; De Coen K; Costrop L; Coucke PJ; Vanhaesebrouck P; De Paepe A
    J Pediatr; 2011 Aug; 159(2):347-9. PubMed ID: 21704322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.
    Harrington DJ; Underwood S; Morse C; Shearer MJ; Tuddenham EG; Mumford AD
    Thromb Haemost; 2005 Jan; 93(1):23-6. PubMed ID: 15630486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
    Loriot MA; Beaune P
    Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9.
    Loebstein R; Vecsler M; Kurnik D; Austerweil N; Gak E; Halkin H; Almog S
    Clin Pharmacol Ther; 2005 May; 77(5):365-72. PubMed ID: 15900282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved expression of recombinant human factor IX by co-expression of GGCX, VKOR and furin.
    Liu J; Jonebring A; Hagström J; Nyström AC; Lövgren A
    Protein J; 2014 Apr; 33(2):174-83. PubMed ID: 24567122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrence of the p.R277X/p.R1511X compound heterozygous mutation in the thyroglobulin gene in unrelated families with congenital goiter and hypothyroidism: haplotype analysis using intragenic thyroglobulin polymorphisms.
    Caputo M; Rivolta CM; Gutnisky VJ; Gruñeiro-Papendieck L; Chiesa A; Medeiros-Neto G; González-Sarmiento R; Targovnik HM
    J Endocrinol; 2007 Oct; 195(1):167-77. PubMed ID: 17911408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver-specific γ-glutamyl carboxylase-deficient mice display bleeding diathesis and short life span.
    Azuma K; Tsukui T; Ikeda K; Shiba S; Nakagawa K; Okano T; Urano T; Horie-Inoue K; Ouchi Y; Ikawa M; Inoue S
    PLoS One; 2014; 9(2):e88643. PubMed ID: 24520408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Molecular mechanism of vitamin K and its regulators in bone metabolism].
    Tsukui T; Imazawa Y; Inoue S
    Clin Calcium; 2007 Nov; 17(11):1685-91. PubMed ID: 17982188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of vitamin K-dependent coagulation factor deficiency and subarachnoid hemorrhage.
    Chen HF; Wu TQ; Jin LJ; Tang JQ; Zhu JJ; Ge YC; Li ZY; Shen HS; Qin LM; Yu ZQ; Wang ZY
    World J Emerg Med; 2011; 2(1):73-6. PubMed ID: 25214988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular basis of the first reported clinical case of congenital combined deficiency of coagulation factors.
    Jin DY; Ingram BO; Stafford DW; Tie JK
    Blood; 2017 Aug; 130(7):948-951. PubMed ID: 28679738
    [No Abstract]   [Full Text] [Related]  

  • 59. Deeper understanding of carboxylase.
    Morrissey JH
    Blood; 2016 Apr; 127(15):1841-2. PubMed ID: 27081093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of GRP and MGP in the Development of Non-Hemorrhagic VKCFD1 Phenotypes.
    Ghosh S; Oldenburg J; Czogalla-Nitsche KJ
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.